卓正医疗招股进行时：稀缺健康消费龙头，高粘性会员体系成长潜力十足

Core Viewpoint - Zhuozheng Medical has successfully launched its IPO, attracting significant investor interest in the mid-to-high-end healthcare service market, with a global offering of 4.75 million shares at a maximum price of 66.6 HKD, expected to be listed on February 6 [1][2] Industry Overview - The private healthcare service industry has experienced a slowdown in growth over the past year, leading to a clearer divide between strong and weak players, with top companies continuing to grow steadily while many smaller institutions face challenges and exit the market [1] - The industry is undergoing a reshaping phase, with Zhuozheng Medical reporting impressive growth despite the downturn, achieving a compound annual growth rate (CAGR) of 42.2% in revenue and 126.7% in gross profit from 2022 to 2024 [1] Business Model - Zhuozheng Medical's unique business model, likened to "Costco of healthcare services," focuses on a family doctor-centered membership plan that provides a one-stop multi-specialty medical service, enhancing customer loyalty and engagement [3][4] - The company targets high-frequency healthcare services, covering a wide range of needs from disease prevention to chronic disease management, thus avoiding competition with public hospitals in low-frequency, high-acuity cases [3][4] Financial Performance - From 2022 to 2024, Zhuozheng Medical's revenue increased from 470 million to 960 million CNY, with a CAGR of 42.2%, and gross profit surged from 43.98 million to 230 million CNY, with a CAGR of 126.7% [6] - The company achieved positive operating cash flow over the past three years, indicating a healthy self-sustaining capability, with marketing expenses significantly lower than industry averages [6][7] Market Position - Zhuozheng Medical's revenue is primarily cash-based (over 85%), with minimal reliance on national insurance, providing a buffer against policy fluctuations in the healthcare sector [7] - The company is strategically positioned in the mid-to-high-end healthcare market, with a network covering ten cities in China and expansion into overseas markets like Singapore and Malaysia [9] Team and Technology - The company boasts a high-quality team of 387 full-time doctors, with an average of 15 years of clinical experience, primarily sourced from top-tier hospitals [10] - Zhuozheng Medical is integrating AI into its service chain, enhancing operational efficiency and paving the way for future collaborations with tech companies [10] Conclusion - Zhuozheng Medical is well-positioned to capitalize on the shift in the private healthcare sector from scale to quality, leveraging its unique membership model and low dependency on marketing and insurance to create a sustainable growth trajectory [11]